Search

everythinglearnresearchcommunity

for

Search:↓

Early hair whitening may indicate a higher risk of heart disease in young and middle-aged men.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

The document suggests that there might be an autoimmune link between polycystic ovary syndrome and Graves' disease.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

The document suggests various treatments for PCOS, including medication for menstrual issues, insulin resistance, and excess hair, as well as fertility treatments, while highlighting the need for personalized care and lifestyle changes.

Medicinal plants may be an effective alternative for treating acne.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Insulin resistance is common in PCOS patients and linked to obesity and increased cardiovascular risk.

Hair aging and loss are caused by genetics, hormones, environment, and grooming, with treatments like minoxidil effective for certain types of hair loss.

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.

Taiwanese women with PCOS experience different symptoms based on age, with younger women facing more hormone imbalances and older women dealing with more metabolic issues.

Women with AGA have higher lipid levels, increasing heart disease risk.

Microemulsions and nanoemulsions can effectively deliver drugs through the skin, but more research is needed to understand their differences and mechanisms.

Microparticles help caffeic acid stay longer in hair follicles for better treatment of folliculitis.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

CBG may help with various medical conditions but needs more human research to confirm safety and effectiveness.

Alfacalcidiol and metformin together lowered testosterone in women with PCOS, but did not significantly improve acne, hair growth, or pregnancy rates.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Liposomes improve the delivery and effectiveness of cosmetic ingredients but face challenges like cost and stability.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Surgical removal of abnormal fat pads fixed the woman's eyelid issue caused by likely silicone injections.

The surgery effectively promoted and maintained weight loss in obese women during the first year.

A low-starch/low-dairy diet may help overweight women with PCOS lose weight and improve metabolism, but more research is needed.

The conclusion is that a thorough approach is needed to diagnose and manage hyperandrogenism in teenage girls, recognizing its major psychological and health effects.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

Healthcare providers need better understanding and cultural sensitivity to improve care for transgender patients with kidney failure needing transplants.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.